Outcome of Imatinib Treatment in Yemeni Patients With Chronic Myeloid Leukemia and the Influence of Nonadherence to Treatment and Duration of Previous Hydroxyurea Therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Outcome of Imatinib Treatment in Yemeni Patients With Chronic Myeloid Leukemia and the Influence of Nonadherence to Treatment and Duration of Previous Hydroxyurea Therapy

Published:2020-03 Issue:3 Volume:20 Page:e144-e153
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Al-Ghazaly Jameel^ORCID,Al-Dubai Waled,Noaman Yousr,Abdullah Munasser,Al-Gharasi Leila,Rosti Gianantonio

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference52 articles.

1. Chronic myelogenous leukemia and related disorders;Liesveld,2016

2. Chronic myeloid leukemia;Lee;Br J Hematol,2000

3. The biology of chronic myeloid leukemia;Faderl;N Engl J Med,1999

4. European Leukemia Net. Chronic myeloid leukemia;Hehlmann;Lancet,2007

5. Hydroxyurea versus busulfan in the treatment of chronic myelogenous leukemia;Rushing;Am J Clin Oncol,1982

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP